SEK 98.05
(1.24%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 2.46 Billion SEK | -87.36% |
2022 | 11.34 Billion SEK | 8.49% |
2021 | 10.46 Billion SEK | 4.53% |
2020 | 10 Billion SEK | -1.22% |
2019 | 10.13 Billion SEK | 85.6% |
2018 | 5.45 Billion SEK | 4.12% |
2017 | 5.24 Billion SEK | 1.12% |
2016 | 5.18 Billion SEK | 31.23% |
2015 | 3.95 Billion SEK | 1.86% |
2014 | 3.87 Billion SEK | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 3.11 Billion SEK | 714.4% |
2024 Q2 | 334 Million SEK | -89.26% |
2023 Q4 | 382 Million SEK | -86.71% |
2023 Q3 | 2.87 Billion SEK | -4.96% |
2023 Q1 | 2.93 Billion SEK | -0.94% |
2023 Q2 | 3.02 Billion SEK | 3.03% |
2023 FY | 1.43 Billion SEK | -87.36% |
2022 Q2 | 2.83 Billion SEK | 0.64% |
2022 FY | 11.34 Billion SEK | 8.49% |
2022 Q4 | 2.96 Billion SEK | 8.02% |
2022 Q3 | 2.74 Billion SEK | -3.07% |
2022 Q1 | 2.81 Billion SEK | -0.53% |
2021 FY | 10.46 Billion SEK | 4.53% |
2021 Q1 | 2.51 Billion SEK | 1.08% |
2021 Q2 | 2.64 Billion SEK | 5.04% |
2021 Q3 | 2.47 Billion SEK | -6.62% |
2021 Q4 | 2.82 Billion SEK | 14.45% |
2020 Q1 | 2.57 Billion SEK | -1.79% |
2020 Q2 | 2.56 Billion SEK | -0.58% |
2020 Q4 | 2.49 Billion SEK | 4.62% |
2020 Q3 | 2.38 Billion SEK | -6.99% |
2020 FY | 10 Billion SEK | -1.22% |
2019 FY | 10.13 Billion SEK | 85.6% |
2019 Q4 | 2.62 Billion SEK | 5.94% |
2019 Q3 | 2.47 Billion SEK | -7.41% |
2019 Q2 | 2.67 Billion SEK | 13.17% |
2019 Q1 | 2.36 Billion SEK | 64.37% |
2018 FY | 5.45 Billion SEK | 4.12% |
2018 Q4 | 1.43 Billion SEK | 9.61% |
2018 Q3 | 1.31 Billion SEK | -4.86% |
2018 Q2 | 1.37 Billion SEK | 3.38% |
2018 Q1 | 1.33 Billion SEK | -1.77% |
2017 Q3 | 1.27 Billion SEK | -2.45% |
2017 FY | 5.24 Billion SEK | 1.12% |
2017 Q4 | 1.35 Billion SEK | 6.51% |
2017 Q1 | 1.3 Billion SEK | -20.72% |
2017 Q2 | 1.3 Billion SEK | 0.08% |
2016 Q1 | 1.1 Billion SEK | 0.0% |
2016 FY | 5.18 Billion SEK | 31.23% |
2016 Q4 | 1.64 Billion SEK | 38.9% |
2016 Q3 | 1.18 Billion SEK | -5.35% |
2016 Q2 | 1.25 Billion SEK | 13.82% |
2015 FY | 3.95 Billion SEK | 1.86% |
2014 FY | 3.87 Billion SEK | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Attendo AB (publ) | 4.64 Billion SEK | 47.017% |
Humana AB (publ) | 376 Million SEK | -554.255% |
ProstaLund AB (publ) | 31.95 Million SEK | -7597.362% |